Elevance Health Inc (ELV)
Return on equity (ROE)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 5,980,000 | 6,418,000 | 6,691,000 | 6,244,000 | 6,002,000 | 6,123,000 | 6,447,000 | 6,244,000 | 6,019,000 | 6,167,000 | 6,056,000 | 6,207,000 | 6,095,000 | 5,521,000 | 4,241,000 | 4,716,000 | 4,572,000 | 4,955,000 | 5,916,000 | 4,779,000 |
| Total stockholders’ equity | US$ in thousands | 41,315,000 | 43,775,000 | 42,191,000 | 40,608,000 | 39,306,000 | 38,423,000 | 38,205,000 | 37,356,000 | 36,243,000 | 35,991,000 | 35,812,000 | 35,975,000 | 36,060,000 | 35,737,000 | 34,968,000 | 33,853,000 | 33,199,000 | 33,921,000 | 34,455,000 | 31,693,000 |
| ROE | 14.47% | 14.66% | 15.86% | 15.38% | 15.27% | 15.94% | 16.87% | 16.71% | 16.61% | 17.13% | 16.91% | 17.25% | 16.90% | 15.45% | 12.13% | 13.93% | 13.77% | 14.61% | 17.17% | 15.08% |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $5,980,000K ÷ $41,315,000K
= 14.47%
Return on equity (ROE) is a key financial ratio that measures a company's profitability by evaluating how efficiently it is utilizing its shareholders' equity. In the case of Elevance Health Inc, the ROE has fluctuated over the past few years, as per the provided data.
From March 31, 2020, to December 31, 2024, Elevance Health Inc's ROE ranged from a low of 12.13% to a high of 17.25%. The trend of ROE shows some variability, with fluctuations in each quarter. Notably, the ROE exceeded 15% for most of the periods, indicating that the company has generally been generating a healthy return on the equity invested by its shareholders.
It is important to note that a higher ROE suggests that the company is effectively generating profit with the equity available to its shareholders. On the other hand, a declining trend in ROE may indicate inefficiency in utilizing shareholders' equity or a decrease in profitability.
Overall, Elevance Health Inc's ROE performance indicates a relatively stable and satisfactory level of profitability and efficiency in utilizing shareholders' equity during the analyzed period. However, ongoing monitoring of ROE trends and further analysis of the company's financial performance would be beneficial to assess its long-term profitability and sustainability.
Peer comparison
Dec 31, 2024